Go Pro

ICU Medical (ICUI) Competitors

ICU Medical logo
$157.34 -0.17 (-0.11%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$157.34 +0.00 (+0.00%)
As of 07/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICUI vs. COO, ALGN, MMSI, HAE, and XRAY

Should you buy ICU Medical stock or one of its competitors? MarketBeat compares ICU Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ICU Medical include Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry.

How does ICU Medical compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 2.15%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
ICU Medical 2.15%7.50%3.91%

Cooper Companies currently has a consensus target price of $81.85, suggesting a potential upside of 14.33%. ICU Medical has a consensus target price of $168.40, suggesting a potential upside of 7.03%. Given Cooper Companies' higher possible upside, research analysts clearly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 2.1% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cooper Companies has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.41$374.90M$1.1860.67
ICU Medical$2.23B1.76$730K$1.8585.05

In the previous week, Cooper Companies had 13 more articles in the media than ICU Medical. MarketBeat recorded 17 mentions for Cooper Companies and 4 mentions for ICU Medical. Cooper Companies' average media sentiment score of 1.32 beat ICU Medical's score of 0.44 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
13 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
ICU Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Cooper Companies beats ICU Medical on 11 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Align Technology?

ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Align Technology has a net margin of 10.50% compared to ICU Medical's net margin of 2.15%. Align Technology's return on equity of 15.82% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical2.15% 7.50% 3.91%
Align Technology 10.50%15.82%10.17%

Align Technology has higher revenue and earnings than ICU Medical. Align Technology is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.76$730K$1.8585.05
Align Technology$4.03B3.11$410.35M$5.9629.37

ICU Medical has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Align Technology had 4 more articles in the media than ICU Medical. MarketBeat recorded 8 mentions for Align Technology and 4 mentions for ICU Medical. Align Technology's average media sentiment score of 0.76 beat ICU Medical's score of 0.44 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Align Technology
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

ICU Medical presently has a consensus price target of $168.40, suggesting a potential upside of 7.03%. Align Technology has a consensus price target of $206.07, suggesting a potential upside of 17.72%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Align Technology beats ICU Medical on 12 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Merit Medical Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

In the previous week, ICU Medical had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for ICU Medical and 3 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.01 beat ICU Medical's score of 0.44 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ICU Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Merit Medical Systems currently has a consensus target price of $92.80, indicating a potential upside of 23.45%. ICU Medical has a consensus target price of $168.40, indicating a potential upside of 7.03%. Given Merit Medical Systems' higher probable upside, equities analysts clearly believe Merit Medical Systems is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 2.1% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Merit Medical Systems has a net margin of 9.03% compared to ICU Medical's net margin of 2.15%. Merit Medical Systems' return on equity of 13.54% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
ICU Medical 2.15%7.50%3.91%

Merit Medical Systems has higher earnings, but lower revenue than ICU Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.54B2.91$128.49M$2.3132.54
ICU Medical$2.23B1.76$730K$1.8585.05

Summary

Merit Medical Systems beats ICU Medical on 10 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Haemonetics?

ICU Medical (NASDAQ:ICUI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

ICU Medical has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Haemonetics has lower revenue, but higher earnings than ICU Medical. Haemonetics is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.76$730K$1.8585.05
Haemonetics$1.33B2.67$97.31M$2.0238.78

ICU Medical currently has a consensus target price of $168.40, suggesting a potential upside of 7.03%. Haemonetics has a consensus target price of $78.89, suggesting a potential upside of 0.70%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe ICU Medical is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

Haemonetics has a net margin of 7.29% compared to ICU Medical's net margin of 2.15%. Haemonetics' return on equity of 27.30% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical2.15% 7.50% 3.91%
Haemonetics 7.29%27.30%9.59%

In the previous week, Haemonetics had 3 more articles in the media than ICU Medical. MarketBeat recorded 7 mentions for Haemonetics and 4 mentions for ICU Medical. Haemonetics' average media sentiment score of 0.90 beat ICU Medical's score of 0.44 indicating that Haemonetics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Haemonetics
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 2.1% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Haemonetics beats ICU Medical on 10 of the 17 factors compared between the two stocks.

How does ICU Medical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

DENTSPLY SIRONA currently has a consensus price target of $13.42, indicating a potential downside of 0.32%. ICU Medical has a consensus price target of $168.40, indicating a potential upside of 7.03%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts plainly believe ICU Medical is more favorable than DENTSPLY SIRONA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DENTSPLY SIRONA
3 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00

ICU Medical has a net margin of 2.15% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
DENTSPLY SIRONA-17.06% 18.83% 5.13%
ICU Medical 2.15%7.50%3.91%

In the previous week, ICU Medical had 1 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 4 mentions for ICU Medical and 3 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.29 beat ICU Medical's score of 0.44 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DENTSPLY SIRONA
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ICU Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DENTSPLY SIRONA$3.68B0.73-$598M-$3.15N/A
ICU Medical$2.23B1.76$730K$1.8585.05

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 2.1% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

DENTSPLY SIRONA has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Summary

ICU Medical beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

Get ICU Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.94B$8.90B$6.89B$12.28B
Dividend YieldN/A2.48%2.67%9.39%
P/E Ratio85.0516.0427.0723.94
Price / Sales1.766.77515.4590.30
Price / Cash10.8018.5526.6847.25
Price / Book1.833.2610.426.14
Net Income$730K$230.22M$3.60B$331.74M
7 Day Performance2.51%-1.77%-1.26%-1.81%
1 Month Performance12.09%-1.97%1.07%-1.44%
1 Year Performance29.33%-0.92%23.61%16.33%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUI
ICU Medical
2.9636 of 5 stars
$157.34
-0.1%
$168.40
+7.0%
+28.5%$3.94B$2.23B85.0513,000
COO
Cooper Companies
3.1502 of 5 stars
$71.32
+0.9%
$81.85
+14.8%
-1.4%$13.79B$4.09B60.4415,000
ALGN
Align Technology
3.3588 of 5 stars
$180.59
+0.6%
$206.07
+14.1%
-8.2%$12.85B$4.03B30.3020,290
MMSI
Merit Medical Systems
4.05 of 5 stars
$73.26
-0.2%
$92.80
+26.7%
-9.5%$4.38B$1.52B31.717,500
HAE
Haemonetics
2.5197 of 5 stars
$76.96
+1.0%
$78.33
+1.8%
+8.0%$3.46B$1.33B38.103,009

Related Companies and Tools


This page (NASDAQ:ICUI) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners